Title:Past, Present and Future of Antiepileptic Drug Therapy - Finding a Place for Heterocyclics
Volume: 15
Issue: 12
Author(s): Ruhi Ali, Mohammad Ahmed Khan and Nadeem Siddiqui
Affiliation:
Keywords:
Antiepileptic drugs, epilepsy, heterocycles, seizure, tonic-clonic.
Abstract: Epilepsy is a serious brain condition characterized by recurring seizures. It affects millions
of people across the globe. Much advancement in the past has improved the understanding of the
underlying pathophysiology and risk factors for epilepsy. These advances have led to the development
of both new terminologies and classification as well as treatment strategies for the disease. Despite the
fact that various antiepileptic drugs have been developed in past decades, major part of affected
population remains either resistant or refractory to the currently available therapy. Also, none of these
anticonvulsant agents are devoid of serious side effect. Therefore, constant efforts are being made to develop antiepileptic
drugs with improved efficacy and better pharmacokinetic and safety profile. The new structural classes which are being
developed broadly amides, amino acids and a number of heterocyclic agents like oxadiazoles, benzimidazoles,
benzothazoles, pyrazoles, indoles and benzothaizoles etc. These new compounds have potential for identification of novel
targets and drug development. This review makes a note of these issues and describes recent developments in antiepileptic
drug discovery.